Natco settles generic Carfilzomib Injection patent litigation in US; stock down 1%

NATCO believes that its 10mg ANDA is sole first to file and could be eligible for 180-days marketing exclusivity for the 10mg strength under certain circumstances.

from India Infoline News Service http://bit.ly/2Mfsnf3